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Introduction: Painful Diabetic Neuropathy is a distressing and disabling complication 
of diabetes mellitus commonly associated with pain, sleep disturbance and poor 
quality of life.  Current treatment is mainly pharmacological, which can be 
beneficial, but in many patients is ineffective or not tolerated and so patients can be 
left without any effective alternative treatment. In this single-blind placebo 
controlled RCT pilot study, we assessed the effectivess, practicality and feasibility of 
acupuncture as an alternative treatment for PDN. 
Patients and method: Fifty-one DM patients currently taking medication for PDN were 
recruited into the study.  Patients with active foot ulcers, peripheral arterial disease 
and previous exposure to acupuncture were excluded.  23 (45%) were received active 
acupuncture and 28 (54%) sham acupuncture. The intervention consisted of 10 
treatment sessions using pain measured on a 10cm visual analogue scale (VAS) as the 
principal outcome measure. Secondary outcomes included the Leeds Assessment of 
Neuropathic Symptoms and Signs (LANSS) to assess changes in signs and symptoms, 
Sleep Problem Scale, and the Measure Yourself Medical Outcome Profile (MYMOP); all 
done at visits 0, 5 and 10.  Resting blood pressure (BP) was taken at each visit. 
Results: Of the 51 patients, 80% completed the final assessment.  The drop-out rate 
was lower in the acupuncture group (14% vs 25% p=0.28). Participants in the active 
acupuncture group showed clinically important percentage improvements in all of the 
outcome measures: VAS (22% vs 18% p=0.49); Sleep (20% vs 6% p=0.43); MYMOP (19% 
vs 9% p=0.12) & LANNS (12% vs 3% p=0.34).  Significant reductions were also observed 
in systolic BP (7% vs -0.3% p=0.03) but not diastolic BP (7.3% vs 2.2% p=0.18). 
Conclusions: In this pilot RCT we have demonstrated the practicality and feasibility of 
introducing acupuncture into the everyday management of patients with PDN.  
Ongoing analysis of SF36 data and saliva cortisol levels will help to corroborate these 
results.  Larger RCTs, however, will be needed to confirm the clinical and cost 
effectiveness of this intervention. 
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